START Madrid-CIOCC, Hospital Universitario HM Sanchinarro

Madrid 28050

4 studies enrolling now · 5 studies all time

What they study most

Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency), Brain Metastases From HER2 and Breast Cancer, Brain Metastases From Solid Tumors, CNS Metastases, Carcinoma, Non-Small-Cell Lung, Endometrial Cancer, Esophageal Squamous Cell Carcinoma, Gastric Cancer, HER2, HER2 + Breast Cancer, HER2 + Gastric Cancer, HER2 Mutation-Related Tumors

Studies at this site

• A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours — Recruiting now
• A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors — Recruiting now
• Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies — Recruiting now
• A Phase 1/1b Study of IAM1363 in HER2 Cancers — Recruiting now
• Safety and Preliminary Efficacy Trial of BNT142 in Patients With CLDN6-positive Solid Tumors — Stopped early